Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATORVASTATIN Cause Blood triglycerides increased? 228 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 228 reports of Blood triglycerides increased have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.3% of all adverse event reports for ATORVASTATIN.

228
Reports of Blood triglycerides increased with ATORVASTATIN
0.3%
of all ATORVASTATIN reports
1
Deaths
31
Hospitalizations

How Dangerous Is Blood triglycerides increased From ATORVASTATIN?

Of the 228 reports, 1 (0.4%) resulted in death, 31 (13.6%) required hospitalization, and 8 (3.5%) were considered life-threatening.

Is Blood triglycerides increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 228 reports have been filed with the FAERS database.

What Other Side Effects Does ATORVASTATIN Cause?

Type 2 diabetes mellitus (7,556) Myalgia (7,155) Drug hypersensitivity (3,929) Drug ineffective (3,865) Fatigue (3,439) Arthralgia (3,338) Rhabdomyolysis (3,286) Dyspnoea (3,137) Nausea (2,888) Asthenia (2,791)

What Other Drugs Cause Blood triglycerides increased?

ISOTRETINOIN (927) EVOLOCUMAB (551) ADALIMUMAB (289) ROSUVASTATIN (287) CLOZAPINE (219) OLANZAPINE (219) EVEROLIMUS (215) ICOSAPENT ETHYL (207) METFORMIN (199) TOFACITINIB (198)

Which ATORVASTATIN Alternatives Have Lower Blood triglycerides increased Risk?

ATORVASTATIN vs ATORVASTATIN\EZETIMIBE ATORVASTATIN vs ATOSIBAN ATORVASTATIN vs ATOVAQUONE ATORVASTATIN vs ATOVAQUONE\PROGUANIL ATORVASTATIN vs ATRACURIUM

Related Pages

ATORVASTATIN Full Profile All Blood triglycerides increased Reports All Drugs Causing Blood triglycerides increased ATORVASTATIN Demographics